• Article  

      HIV cascade of care in Greece: Useful insights from additional stages 

      Nikolopoulos, Georgios; Vourli, Georgia; Paparizos, Vasilios; Skoutelis, Athanasios; Metallidis, Symeon; Gargalianos, Panagiotis; Papadopoulos, Antonios; Chini, Maria; Sipsas, Nikolaos V.; Psychogiou, Mina; Chrysos, Georgios; Sambatakou, Helen; Gogos, Charalambos; Katsarou, Olga; Paraskeva, Dimitra; Dedes, Nikos; Touloumi, Giota; Group, on behalf of the Greek HIV Prevention (2018)
      Background Aiming to eliminate HIV infection, UNAIDS has set a global “90-90-90” target by 2020. We sought to construct a 6-stages HIV Cascade of Care (CoC) in Greece, overall and by risk group, to assess risk-group and ...
    • Article  

      Increasing prevalence of HIV-1 subtype a in Greece: Estimating epidemic history and origin 

      Paraskeva, D.; Magiorkinis, Emmanouil; Magiorkinis, Gkikas; Sypsa, V.; Paparizos, V.; Lazanas, Marios; Gargalianos, Panagiotis; Antoniadou, Anastasia; Panos, G.; Chrysos, Georgios; Sambatakou, H.; Karafoulidou, Anastasia; Skoutelis, A.; Kordossis, Theodoros; Koratzanis, Georgios; Theodoridou, M.; Daikos, Georgios L.; Nikolopoulos, Georgios K.; Pybus, O. G.; Hatzakis, A. (2007)
      Background. In North America and Europe, human immunodeficiency virus (HIV)-1 infection has typically been dominated by subtype B transmission. More recently, however, non-B subtypes have been increasingly reported in ...
    • Article  

      Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003–2015: Transmitted drug resistance is due to onward transmissions 

      Paraskeva, D.; Kostaki, Evangelia-Georgia; Magiorkinis, Gkikas; Gargalianos, Panagiotis; Xylomenos, G.; Magiorkinis, Emmanouil; Lazanas, Marios; Chini, M.; Nikolopoulos, Georgios K.; Skoutelis, A.; Papastamopoulos, V.; Antoniadou, Anastasia; Papadopoulos, A.; Psichogiou, M.; Daikos, Georgios L.; Oikonomopoulou, M.; Zavitsanou, A.; Chrysos, Georgios; Paparizos, V.; Kourkounti, S.; Sambatakou, H.; Sipsas, N. V.; Lada, M.; Panagopoulos, P.; Maltezos, E.; Drimis, S.; Hatzakis, A. (2017)
      Background The prevalence of HIV-1 drug resistance among treatment-naïve patients ranges between 8.3% and 15% in Europe and North America. Previous studies showed that subtypes A and B were the most prevalent in the Greek ...